• Asthma

We write to raise concerns about the recent paper by Chapman et al on single maintenance and reliever therapy (SMART) of asthma,1 on the basis that it misrepresents published scientific evidence. The errors include:

1. Reporting outcome measures for one treatment arm from several double-blind studies (table 1 and accompanying text), but omitting the published data2 for comparator arms from the same studies which would have been highly relevant …